AlphaYouCB
Insider buying
Christian Behrenbruch bought $997K of Telix Pharmaceuticals Ltd (TLX) stock
Christian Behrenbruch, MD & Group CEO of Telix Pharmaceuticals Ltd (TLX), bought 67,935 shares of TLX stock worth $997K, per an SEC Form 4 filed May 7, 2026.
It was an open-market purchase.
The trade happened on Apr 28, 2026, 9 days before it was made public.
TLX has moved +8.3% since the trade date, from $10.44 to $11.31 (Sep 21, 2026 close).
- Traded
- Apr 28, 2026
- Disclosed
- May 7, 2026
- Filing delay
- 9 days
- Price since
- +8.3%
- Role
- MD & Group CEO
- Source
- SEC Form 4
More TLX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.